Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/22/10 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 01/28/10 | 10-Q/A | Quarterly report pursuant to Section 13 or 15(d) |
|
28 | |
| 01/21/10 | 10-Q/A | Quarterly report pursuant to Section 13 or 15(d) |
|
27 | |
| 01/21/10 | 10-Q/A | Quarterly report pursuant to Section 13 or 15(d) |
|
24 | |
| 01/21/10 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
54 | |
| 01/19/10 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/15/09 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
3 | |
| 12/07/09 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/24/09 | 8-K | Current report filing |
|
2 | |
| 11/23/09 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 |
